(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The Rare Lung Diseases Program is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs. Learn more about our faculty and staff.
Christopher Towe, MD Director, Rare Lung Diseases Program 513-636-6771 firstname.lastname@example.org
Director, Rare Lung Diseases Program
Assistant Professor, UC Department of Pediatrics
Childhood interstitial lung diseases; lung transplantation
MD: University of Texas Southwestern School of Medicine, Dallas, TX, 2008.
Residency: Pediatrics, St. Louis Children's Hospital, St. Louis, MO, 2011.
Fellowship: Pediatric Pulmonary, Washington University School of Medicine, St. Louis, MO, 2014.
Certification: Pediatric Pulmonary, 2014; Pediatrics, 2012.
Mahmoud M, Towe C, Fleck R. CT chest under general anesthesia: pulmonary, anesthetic and radiologic dilemmas. Pediatr Radiol. 2014 Dec.
Towe C, Ogborn AC, Ferkol T, Sweet S, Huddleston C, White F, Faro A. Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplant. J Heart and Lung Transplantation. 2014 Nov.
Szafranski P, Dharmadhikari AV, Wambach JA, Towe CT, White FV, Grady RM, Eghtesady P, Cole FS, Deutsch G, Sen P, Stankiewicz P. Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins. Am J Med Genet A. 2014 Aug;164A(8):2013-9.
Bruce C. Trapnell, MS, MD Assistant Director, Adult Cystic Fibrosis Center 513-636-6361 email@example.com
Assistant Director, Adult Cystic Fibrosis Center
Pulmonologist - Research, Adult Clinical, Division of Pulmonary Medicine
Professor, UC Department of Pediatrics
Pulmonary alveolar proteinosis; cystic fibrosis; alpha-1 antitrypsin deficiency; other rare lung disorders
Bruce Trapnell, MS, MD, received his medical degree from the University of Maryland in 1985, and completed a medical residency at The Ohio State University Hospitals and a fellowship in pulmonary medicine at the Clinical Center of the National Institutes of Health, where he then served as senior attending physician. Subsequently, he established the Division of Pulmonary and Virology Studies at Genetic Therapy, Inc., a subsidiary of Novartis, Pharma, serving as vice president before joining Cincinnati Children’s Hospital Medical Center, where he is now full professor.
Dr. Trapnell has conducted lung disease research since his training and has been continuously funded by the NIH since 2001, shortly after his arrival in Cincinnati. He has published over 90 original articles and has trained more than 16 post-doctoral fellows. Dr. Trapnell’s research interests are focused to the pathogenesis and therapy of rare lung diseases and mechanisms by which GM-CSF regulates innate immunity and lung host defense.
Dr. Trapnell is director of Cincinnati’s Cystic Fibrosis Therapeutics Development Network Center, assistant director of the Adult Cystic Fibrosis Care Center, director of the Rare Lung Diseases Clinical Research Consortium, scientific director of the Pulmonary Alveolar Proteinosis Foundation. Dr. Trapnell is the past scientific director of the Alpha-1 Foundation, for which he organized and directed the grant program for eight years.
MS: Genetics, The George Washington University, Washington, DC, 1981.
MD: University of Maryland School of Medicine, Baltimore, MD, 1984.
Residency: Internal Medicine, The Ohio State University Hospitals, Columbus, OH, 1987.
Fellowship: Pulmonary Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD, 1989.
Certification: Diplomate in Internal Medicine, American Board of Internal Medicine, 1987; Diplomate, National Board of Medical Examiners, 1987; Diplomate in Pulmonary Medicine, American Board of Internal Medicine, 2000.
Wu H, Suzuki T, Carey B, Trapnell BC, McCormack FX. Keratinocyte growth factor (KGF) augments pulmonary innate immunity through epithelium-driven, GM-CSF dependent paracrine activation of alveolar macrophages. J Biol Chem. 2011 Feb 22.
D'Mello S, Trauernicht A, Ryan A, Bonkowski E, Willson T, Trapnell BC, Frank SJ, Kugasathan S, Denson LA. Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis. Inflamm Bowel Dis. 2011 Feb 18.
Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, Whitsett JA, Stevens C, Nogee LM, Campo I, Trapnell BC. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304.
Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest. 2010 Sep;138(3):674-81.
Han X, Gilbert S, Groschwitz K, Hogan S, Jurickova I, Trapnell B, Samson C, Gully J. Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury. Gut. 2010 Aug;59(8):1066-78.
Sakagami T, Beck D, Uchida K, Suzuki T, Carey BC, Nakata K, Keller G, Wood RE, Wert SE, Ikegami M, Whitsett JA, Luisetti M, Davies S, Krischer JP, Brody A, Ryckman F, Trapnell BC. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med. 2010 Jul 1;182(1):49-61.
Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010 May;135(2):223-35.
Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros. 2009 Dec;8(6):370-7.
Trapnell BC, Carey BC, Uchida K, Suzuki T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol. 2009 Oct;21(5):514-21.
Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, Stevens CA, Beck DC, Denson LA, Carey BC, Keicho N, Krischer JP, Yamada Y, Trapnell BC. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood. 2009 Mar 12;113(11):2547-56.
Raouf S. Amin, MD Director, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Director, Division of Pulmonary Medicine
Chronic respiratory failure; sleep disorders in children
Raouf S. Amin, MD, is the director of the Division of Pulmonary Medicine at Cincinnati Children's Hospital Medical Center and a professor for the UC Department of Pediatrics. He graduated from the University of Ain Shams in Cairo Egypt in 1977. Dr. Amin received clinical training in the United Kingdom and the United States. He completed a pulmonary fellowship at Cincinnati Children's Hospital Medical Center in 1993. His research focus is on cardiovascular morbidity of sleep disordered breathing in children. He has several funded protocols from the National Institute of Health.
MD: Aim Shams University, Cairo Egypt, 1978.
Residency: Pediatrics; Michigan State University, Flint, MI.
Certification: Pediatrics 1990; Pediatric Pulmonary Medicine 1994; Sleep Medicine, 1995.
Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, Deboeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, Ordoñez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 2012 Jan;67(1):12-8.
Sung V, Beebe DW, Vandyke R, Fenchel MC, Crimmins NA, Kirk S, Hiscock H, Amin R, Wake M. Does sleep duration predict metabolic risk in obese adolescents attending tertiary services? A cross-sectional study. Sleep. 2011 Jul 1;34(7):891-8.
Sawnani H, Murugappan S, Gutmark E, Donnelly LF, Amin R, Mylavarapu G, Mihaescu M, Khosla S, Kalra M. Influence of gender on pharyngeal airway length in obese adolescents. Ann Otol Rhinol Laryngol. 2010 Dec;119(12):842-7.
Beebe DW, Ris MD, Kramer ME, Long E, Amin R. The association between sleep disordered breathing, academic grades, and cognitive and behavioral functioning among overweight subjects during middle to late childhood. Sleep. 2010 Nov 1;33(11):1447-56.
Beebe DW, Rose D, Amin R. Attention, learning, and arousal of experimentally sleep-restricted adolescents in a simulated classroom. J Adolesc Health. 2010 Nov;47(5):523-5.
McPhail GL, Weiland J, Acton JD, Ednick M, Chima A, VanDyke R, Fenchel MC, Amin RS, Seid M. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med. 2010 Oct;164(10):957-60.
McPhail GL, Ednick MD, Fenchel MC, VanDyke R, Chima A, Amin RS, Seid M. Improving follow-up in hospitalised children. Qual Saf Health Care. 2010 Oct;19(5):e35.
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58.
Ednick M, Tinkle BT, Phromchairak J, Egelhoff J, Amin R, Simakajornboon N. Sleep-related respiratory abnormalities and arousal pattern in achondroplasia during early infancy. J Pediatr. 2009 Oct;155(4):510-5.
McConnell K, Somers VK, Kimball T, Daniels S, VanDyke R, Fenchel M, Cohen A, Willging P, Shamsuzzaman A, Amin R. Baroreflex gain in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2009 Jul 1;180(1):42-8.
Ronald E. Bokulic, DO 513-636-6771
Associate Professor, UC Department of Pediatrics
Asthma; interstitial lung disease; exercise
DO: Philadelphia College of Osteopathic Medicine, 1983.
Residency: Pediatrics, Children's Medical Center, Dallas, TX.
Fellowship: Pediatric Pulmonary Medicine, Tulane University Medical School, New Orleans, LA.
Certification: Pediatrics, 1989; Pediatric Pulmonology, 1994.
Burrow TA, Cohen MB, Bokulic R, Deutsch G, Choudhary A, Falcone RA Jr, Grabowski GA. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy. J Pediatr. 2007 Feb;150(2):202-6.
Amin RS, Carroll JL, Jeffries JL, Grone C, Bean JA, Chini B, Bokulic R, Daniels SR. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med. 2004 Apr 15;169(8):950-6.
Evans DA, Bokulic RE. Radiological case of the month. Posttraumatic pseudocysts. Arch Pediatr Adolesc Med. 1997 Aug;151(8):47-9.
Hardie W, Bokulic R, Garcia VF, Reising SF, Christie CD. Pneumococcal pleural empyemas in children. Clin Infect Dis. 1996 Jun;22(6):1057-63.
Bokulic RE, Hilman BC. Interstitial lung disease in children. Pediatr Clin North Am. 1994 Jun;41(3):543-67.
Carolyn M. Kercsmar, MD Co-Director, Division of Pulmonary Medicine 513-636-6771 email@example.com
Co-Director, Division of Pulmonary Medicine
Director, Asthma Center
BS: Biology, Baldwin-Wallace College, Cleveland, OH, 1972.
MD: Case Western Reserve University, Cleveland, OH, 1978.
MS: Anatomy, Case Western Reserve University, Cleveland, OH, 1978.
Kercsmar C. Exhaled nitric oxide in the diagnosis and management of childhood asthma. Ther Adv Respir Dis. 2010 Apr;4(2):71-82.
Kattan M, Kumar R, Bloomberg GR, Mitchell HE, Calatroni A, Gergen PJ, Kercsmar CM, Visness CM, Matsui EJ, Steinbach SF, Szefler SJ, Sorkness CA, Morgan WJ, Teach SJ, Gan VJ. Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol. 2010 125:584-92.
Rohan J, Drotar D, McNally K, Schluchter M, Riekert K, Vavrek P, Schmidt A, Redline S, Kercsmar C. Adherence to pediatric asthma treatment in economically disadvantaged African-American children and adolescents: an application of growth curve analysis. J Pediatr Psychol. 2010 May;35(4):394-404.
Ross KR, Hart MA, Storfer-Isser A, Kibler AM, Johnson NL, Rosen CL, Kercsmar CM, Redline S. Obesity and obesity related co-morbidities in a referral population of children with asthma. Pediatr Pulmonol. 2009 Sep;44(9):877-84.
McNally KA, Rohan J, Schluchter M, Riekert KA, Vavrek P, Schmidt A, Redline S, Kercsmar C, Drotar D. Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma. J Asthma. 2009 Nov;46(9):921-7.
Kercsmar CM, McDowell KM. Love it or Lev it: Levalbuterol for severe acute asthma; for now, leave it. J Pediatr. 2009 155:163-64.
Short EJ, Kirchner HL, Asaad GR, Fulton S, Lewis B, Eisengart S, Baley J, Kercsmar C, Min MO, Singer LT. Long-term Sequelae of Postnatal Surfactant and Corticosteroid Therapies. BPD J Perinatol. 2008 Jul; 28(7):498-504.
Szefler SL, Mirchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, , Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu, AH, Wildfire JJ, Busse WW. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008 372:1065-72.
Kercsmar CM. Meeting the challenges of asthma: conference summary. Respir Care. 2008 Jun;53(6):787-95.
Sobande PO, Kercsmar CM. Inhaled corticosteroids in asthma management. Respir Care. 2008 May;53(5):625-33; discussion 633-4. Review.
Karen M. McDowell, MD Director, Infant Pulmonary Function Lab 513-636-6771 firstname.lastname@example.org
Director, Infant Pulmonary Function Lab
Asthma; flexible bronchoscopy; general pediatric pulmonology; quality improvement methodologies; infant pulmonary function test
BS: College of William and Mary, Williamsburg, VA, 1983.
MS: University of Connecticut, Storrs, CT, 1986.
MD: Temple University School of Medicine, Philadelphia, PA, 1990.
Residency: Rainbow Babies and Children's Hospital, Cleveland, OH.
Fellowship: Rainbow Babies and Children's Hospital, Cleveland, OH.
Certification: Pediatric Pulmonology, 1996.
McDowell KM, Craven DI. Pulmonary complications of Down syndrome during childhood. J Pediatr. 2011 Feb;158(2):319-25.
Kercsmar CM, McDowell KM. Love It or Lev It: The Role of Levalbuterol in Acute Severe Asthma—For now, Leave it. J Pediatr. 2009 155(2):162-164.
Richards MM, Banez, GA, McDowell KM. Pediatric Puzzler. Pediatric Perspectives. April 2006.
Ogunmola N, Wyllie R, McDowell K, Kay M, Mahajan L. Endoscopic closure of esophagobronchial fistula with fibrin glue. J Pediatr Gastroenterol Nutr. 2004 38(5): 539-541.
Gary Lewis McPhail, MD Cystic Fibrosis Center Director, Division of Pulmonary Medicine 513-636-6771 email@example.com
Cystic Fibrosis Center Director, Division of Pulmonary Medicine
Associate Director, Fellowship Training Program
Medical education; outcomes research; quality improvement; sleep medicine; thoracic insufficiency syndrome
MD: University of Texas Southwestern Medical Center, Dallas TX, 2001.
Residency: Children's Medical Center, University of Texas Southwestern, Dallas TX, 2004.
Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2007.
Certification: Pediatrics, 2004; Pediatric Pulmonary, 2008.
McPhail GL, Weiland J, Acton JD, Ednick M, Chima A, VanDyke R, Fenchel MC, Amin RS, Seid M. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med. 2010 Oct;164(10):957-60.
McPhail GL, Ednick MD, Fenchel MC, VanDyke R, Chima A, Amin RS, Seid M. Improving follow-up in hospitalised children. Qual Saf Health Care. 2010 Oct;19(5):e35
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58. Review.
McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. J Pediatr. 2008 Dec;153(6):752-7.
McPhail GL. Coagulation disorder as a presentation of cystic fibrosis. J Emerg Med. 2010 Apr;38(3):320-2.
Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, McPhail G, Morgenthal A, Fenchel M, Bean J, Kimball T, Daniels S. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension. 2008 Jan;51(1):84-91.
McPhail GL, Hardie WD. Cavitary lung lesions in a 2-year-old child. Respiration. 2008;76(1):117-8.
Robert E. Wood, PhD, MD Director, Pulmonary Bronchoscopy Department 513-636-2776 firstname.lastname@example.org
Director, Pulmonary Bronchoscopy Department
Dr. Robert Wood, PhD, MD, is a pediatric pulmonary specialist, with particular interest in bronchoscopy. He has played a major role in the development of instrumentation and techniques for flexible bronchoscopy in pediatric patients. He is recognized as a teacher of endoscopic techniques, and has published many papers and book chapters on the subject. Additionally, he has extensive experience with clinical problems in pediatric pulmonary medicine, especially children with complex airway problems and cystic fibrosis.
Before coming to Cincinnati Children's Hospital Medical Center, Dr. Wood was on the faculty of Case Western Reserve University in Cleveland, Ohio (1976 to 1983), and the University of North Carolina at Chapel Hill (1983 to 1999).
PhD: Medical Physiology, Vanderbilt University, Nashville, TN, 1968.
MD: Vanderbilt University, Nashville, TN, 1970.
Residency: Pediatrics, Duke University Medical Center, Durham, NC, 1970 to 1972.
Fellowship: Pediatric Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, Bethesda, MD, 1972 to 1974; Pediatric Pulmonology, Case Western Reserve University, Cleveland, OH; Rainbow Babies and Children's Hospital, Cleveland, OH, 1974 to 1976.
Certification: Pediatrics, 1976; Pediatric Pulmonology, 1986, 1997.
Abman S, Jobe A, Chernick V, Blaisdell C, Castro M, Ramirez MI, Gern JE, Cutting G, Redding G, Hagood JS, Whitsett J, Abman S, Raj JU, Barst R, Kato GJ, Gozal D, Haddad GG, Prabhakar NR, Gauda E, Martinez FD, Tepper R, Wood RE, Accurso F, Teague WG, Venegas J, Cole FS, Wright RJ, Gail D, Hamvas A, Kercsmar C, Kiley J, Weinmann G; NHLBI working group report. Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. Pediatr Pulmonol. 2009 Jan;44(1):2-13.
Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Kosepglu ST, Link B, Martin RA, Molter DW, MuAoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E. Multidisciplinary Management of Hunter Syndrome. Pediatrics. 2009; 124:e1228-39.
Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T, Dishop MK, Wert SE, Whitsett JA, Grabowski G, Carey BC, Stevens C, van der Loo JC, Trapnell BC. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med. 2008 Nov 24;205(12):2703-10.
Wood RE. Evaluation of the upper airway in children. Curr Opin Pediatr. 2008 Jun;20(3):266-71. Review.
Boesch RP, Daines C, Willging JP, Kaul A, Cohen AP, Wood RE, Amin RS. Advances in the diagnosis and management of chronic pulmonary aspiration in children. Eur Respir J. 2006 Oct;28(4):847-61. Review.
Zur KB, Wood RE, Elluru RG. Pediatric postcricoid vascular malformation: a diagnostic and treatment challenge. Int J Pediatr Otorhinolaryngol. 2005 Dec;69(12):1697-701.
Lim LH, Cotton RT, Azizkhan RG, Wood RE, Cohen AP, Rutter MJ. Complications of metallic stents in the pediatric airway. Otolaryngol Head Neck Surg. 2004 Oct;131(4):355-61.
Wood RE. The emerging role of flexible bronchoscopy in pediatrics. Clin Chest Med. 2001 Jun;22(2):311-7, viii. Review.
Jackie Taylor, RD
Cystic Fibrosis Dietician, Division of Pulmonary Medicine 513-636-6771 email@example.com
Denise M. Adams, MD Marjory J. Johnson Chair of Vascular Tumor Translational Research 513-636-4266 firstname.lastname@example.org
Marjory J. Johnson Chair of Vascular Tumor Translational Research
Medical Director, Hemangioma and Vascular Malformation Program
Fellowship Director, Hematology / Oncology
Quarmyne MO, Gupta A, Adams DM. Lymphangiosarcoma of the thorax and thoracic vertebrae in a 16-year-old girl. J Clin Oncol. 2012 Oct;30(29):294-8.
Haggstrom AN, Beaumont JL, Lai JS, Adams, DM, Drolet BA, Frieden IJ, Garzon MC, Holland KE, Horii KA, Lucky AW, Mancini AJ, Metry DW, Morel KD, Newell BD, Nopper AJ, Siegel D, Swigonski NL, Cella D, Chamlin SL. Measuring the severity of infantile hemangiomas: instrument development and reliability. Arch Dermatol. 2012 Feb;148(2):197-202.
Fadell MF 2nd, Jones BV, Adams DM. Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol. 2011 Aug;41(8):1057-60.
Maugans T, Sheridan RM, Adams D, Gupta A. Cutaneous vascular anomalies associated with neural tube defects: nomenclature and pathology revisited. Neurosurgery. 2011 Jul;69(1):112-8.
Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011 Dec 1;57(6):1018-24.
Adams DM. Special considerations in vascular anomalies: hematologic management. Clin Plast Surg. 2011 Jan;38(1):153-60.
Duffy KJ, Runge-Samuelson C, Bayer ML, Friedland D, Sulman C, Chun R, Kerschner JE, Metry D, Adams D, Drolet BA. Association of hearing loss with PHACE syndrome. Arch Dermatol. 2010 Dec;146(12):1391-6. Drolet BA, Chamlin SL, Garzon MC, Adams D, Baselga E, Haggstrom AN, Holland KE, Horii KA, Juern A, Lucky AW, Mancini AJ, McCuaig C, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Frieden IJ. Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin. J Pediatr. 2010 Nov;157(5):789-94.
Lomenick JP, Reifschneider KL, Lucky AW, Adams D, Azizkhan RG, Woo JG, Backeljauw PF. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol. 2009 Mar;145(3):262-6.
Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, Adams DM, Azizkhan RG. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg. 2009 Jan;44(1):125-33.
Michael Baker, MD 513-636-4261 email@example.com
Assistant Professor, UC Department of Pathology & Laboratory Medicine
Undergraduate: Louisiana State University, Baton Rouge, LA.
Medical School: Louisiana State University Medical Center, Baton Rouge, LA.
AP/CP Residency: Dartmouth Hitchcock Medical Center, Lebanon, NH.
Pediatric Pathology: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Certifications: Anatomic/Clinical/Pediatric Pathology.
Alan S. Brody, MD Radiologist, Department of Radiology and Medical Imaging 513-636-8508 firstname.lastname@example.org
Radiologist, Department of Radiology and Medical Imaging
Chief, Thoracic Imaging
Assistant Director of Clinical Research
Professor, UC Department of Radiology
Dr. Brody completed his fellowship in pediatric radiology in 1987 and then returned to the Department of Radiology and Medical Imaging at Cincinnati Children’s Hospital Medical Center in 1995. Dr. Brody is active in the Department of Radiology of University of Cincinnati as well as Cincinnati Children’s Hospital Medical Center in clinical care, research, teaching and administration. The primary focus of his clinical duties is pediatric thoracic imaging.
Dr. Brody’s research efforts are focused on the use of CT scanning in the evaluation of cystic fibrosis and diffuse lung disease in children. He began and continues to direct the National Resource Center for Imaging of the Cystic Fibrosis Foundation Therapeutic Development Network. This center is currently funded by the Cystic Fibrosis Foundation and by industry sponsors to provide expertise in the use of imaging endpoints for clinical trials. Dr. Brody is a founding member and chair of the imaging committee of the childhood Interstitial Disease Consortium.
Dr. Brody is a fellow of the American Academy of Pediatrics and is board certified in pediatrics and radiology. He holds a certificate of special qualification in pediatric radiology from the American Board of Radiology. Dr. Brody is a member of multiple national and international medical societies including senior membership in the Society for Thoracic Radiology, and membership in the Fleischner Society. Dr. Brody has been recognized as one of America’s top physicians since 2008.
AB: Biology, Kenyon College, Gambier, OH, 1975.
MD: Albert Einstein College of Medicine, Bronx, NY, 1980.
Residency: Pediatrics, University of California San Francisco, San Francisco, CA, 1980-1983; Radiology, University of California San Francisco, San Francisco, CA, 1983-1986.
Fellowship: Pediatric Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 1986-1987.
Certification: Pediatrics, 1986; Radiology, 1986; Certificate of Additional Qualification in Pediatric Radiology, 1995.
Eric J. Crotty, MD Radiologist, Department of Radiology and Medical Imaging 513-636-2165 email@example.com
Program Director, Pediatric Radiology Fellowship
Assistant Professor, UC Department of Radiology
Pulmonary radiology; cardiac radiology
Eric J. Crotty, PhD, was raised in Cork, Ireland and received his MB, BCh, BAO degree from the University of College Cork, graduating in 1990. Having worked for three years in pediatrics, he undertook a radiology residency program from 1995 to 1999. Subsequently he did a fellowship year in thoracic imaging at Duke University Medical Center, from July 1999 to June 2000, followed by a pediatric radiology fellowship year at Cincinnati Children's Hospital Medical Center from July 2000 to June 2001. He later joined the staff at Cincinnati Children's. He currently is the program director of the Pediatric Radiology Fellowship Program. His interests include education, and cardio thoracic imaging.
MD: University College Cork, Ireland, 1990.
Residency: Radiology, Cork University Hospital, Ireland.
Fellowship in Thoracic Imaging: Duke University Medical Center, Durham, NC, 1999-2000.
Fellowship in Pediatric Radiology: Cincinnati Children's, Cincinnati, OH, 2000-2001.
Certification: FFRRCSI, 1998; American Board of Radiology, 2005; American Board of Radiology-Pediatrics, 2006.
Kim HK, Crotty E. Bilateral testicular adrenal rests in a boy with congenital adrenal hyperplasia. Pediatr Radiol. 2010 Dec;40 Suppl 1:25.
Kim HK, Crotty E. Post-traumatic osteolysis of the distal clavicle. Pediatr Radiol. 2010 May;40(5):784.
Hirsch R, Gottliebson W, Crotty E, Fleck R, Strife J. Computed tomography angiography with three-dimensional reconstruction for pulmonary venous definition in high-risk infants with congenital heart disease. Congenit Heart Dis. 2006 May;1(3):104-10.
Brody AS, Crotty EJ. Neuroendocrine cell hyperplasia of infancy (NEHI). Pediatr Radiol. 2006 Dec;36(12):1328. Wansapura J, Fleck R, Crotty E et al. Frequency scouting for cardiac imaging with SSFP at 3 Tesla. Pediatr Radiol. 2006;36(10):1082-1085.
Wansapura J, Gottliebson W, Crotty E, et al. Cyclic variation of T1 in the myocardium at 3 T. Magn Reson Imaging. 2006. 24(7):889-893.
A. Roshni Dasgupta, MD, MPH Pediatric Surgeon, Division of Pediatric General and Thoracic Surgery 513-636-4371 firstname.lastname@example.org
Pediatric Surgeon, Division of Pediatric General and Thoracic Surgery
Associate Professor, UC Department of Surgery
Surgical oncology and vascular malformations; minimally invasive surgery; general pediatric surgery
Roshni Dasgupta, MD, MPH, is a surgeon with the Hemangioma and Vascular Malformations Center and an associate professor with the University of Cincinnati College of Medicine. She has been involved with the HVMC team for the past eight years. Dr. Dasgupta obtained her medical degree at the University of Toronto. She finished her residency at Massachusetts General Hospital at Harvard Medical School. She completed a Rhodes Scholarship at the University of Oxford in Oxford England, followed by a Pediatric Surgery Fellowship at the Hospital for Sick Children in Toronto, Canada. She has also completed her Master of Public Health at the Harvard School of Public Health.
Dr. Dasgupta has authored multiple articles and book chapters on vascular anomalies and will be the next editor of the vascular anomalies edition of Seminars in Pediatric Surgery. She is interested in post-surgical long term outcomes of patients with vascular anomalies, as well as treatment and outcomes of hemangioma patients.
MD: University of Toronto, Toronto Canada, 1996.
Residency: Massachusetts General Hospital, Harvard Medical School 1996-2003.
Research Fellowship: University of Oxford, Oxford, England.
Fellowship: Hospital for Sick Children, Toronto, Canada.
MPH: Harvard School of Public Health, Boston, MA, 2009.
Hamilton TE, Barnhart D, Gow K, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Gratias E, Geller J, Ehrlich P. Inter-rater reliability of surgical reviews for AREN03B2: A COG renal tumor committee study. J Pediatr Surg. 2014 Jan;49(1):154-8.
Drolet BA, Trenor CC 3, Brandão LR, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, Iacobas I, Jensen JN, King DM, Lee MT, Nelson S, Patel M, Pope E, Powell J, Seefeldt M, Siegel DH, Kelly M, Adams DM. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr. 2013 Jul;163(1):285-91.
Burke ME, Lyden ER, Meza, JL, Ladas EJ, Dasgupta R, Wiegner EA, Arndt CA. Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer. 2013 May;60(5):748-53.
Murrell Z, Dasgupta R. What predicts the risk of recurrent lung metastases? J Pediatr Surg. 2013 May;48(5):1020-4.
Chen W, Gupta A, Adams D, Patel M, Dasgupta R. Generalized lymphatic malformation with chylothorax: long-term management of a highly morbid condition in a pediatric patient. J Pediatr Surg. 2013 Mar;48(3):e9-e12.
Dasgupta R, Rodeberg DA. Update on rhabdomyosarcoma. Semin Pediatr Surg. 2012 Feb; 21(1):68-78.
Rymeski B, Burns K, Nagarajan R, Correll J, Kent D, O'Brien M, Perentesis JP, Dasgupta R. Long-term complications after staging laparotomy for Hodgkin lymphoma. J Clin Oncol 30, 2012.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center